Table 2.
Variable (risk) | HR | [95% CI] | P |
---|---|---|---|
Overall survival | |||
General factor | |||
Sex (male) | 2.262 | [0.746–8.336] | 0.153 |
Primary colorectal cancer related factors | |||
Location (rectum) | 2.042 | [0.698–6.344] | 0.193 |
N stage (N2) | 1.422 | [0.402–4.455] | 0.566 |
Lung metastasis related factors | |||
Preoperative serum CEA (≥5.0 ng/mL) | 3.793 | [1.292–11.955] | 0.015 |
DFI after colorectal cancer resection (<24 months) | 6.424 | [1.708–42.585] | 0.004 |
Disease-free survival | |||
General factor | |||
Sex (male) | 1.929 | [0.893–4.352] | 0.095 |
Primary colorectal cancer related factors | |||
N stage (N2) | 3.106 | [1.232–7.231] | 0.018 |
Vascular invasion (identified) | 2.395 | [0.769–10.536] | 0.141 |
Lung metastasis related factors | |||
Tumor distribution (bilateral) | 2.227 | [0.720–6.147] | 0.156 |
Preoperative serum CEA (≥5.0 ng/mL) | 1.977 | [0.869–4.462] | 0.103 |
DFI after colorectal cancer resection (<24 months) | 2.838 | [1.271–7.224] | 0.010 |
CEA carcinoembryonic antigen, CI confidence interval, DFI disease-free interval, HR hazard ratio